glp-1 anorexia GIP Receptor Agonism Attenuates Receptor Agonist Induced Nausea and Emesis in Preclinical Models — Hayes Lab 504: Adult Eating Disorders in

Our data shows that "choosing drinks that feel healthier or lower in alcohol" ranks dead last amongst entry points in the alcohol category for this audience

Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH

Rezdiffra treats a condition called metabolic dysfunction-associated steatohepatitis or MASH

Women with uterine fibroids have a more than 80 percent higher risk of developing heart disease, according to a new study

But which one should you ask about first